Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MOR MorphoSys
5.030+0.020+0.40%
Trading Session
02/07 13:34 ET
High
5.090
Open
5.090
Turnover
130.79K
Low
4.950
Pre Close
5.010
Volume
25.96K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
MorphoSys (ETR:MOR) Stock Price Up 0.8%
MorphoSys AG (ETR:MOR – Get Rating) shares rose 0.8% on Monday . The company traded as high as €18.34 ($19.93) and last traded at €18.15 ($19.73). Approximately 93,647 shares were traded during trad
Biopharma, Tech Stocks Lead European Equities Slightly Lower
11:10 AM EST, 01/25/2023 (MT Newswires) -- Biopharmaceutical firms and tech stocks led European equities modestly lower in Wednesday trading, as American depositary receipts of European stocks were do
Pharma Stocks Weigh Down European Equities in Tuesday Trading
11:11 AM EST, 01/24/2023 (MT Newswires) -- European equities were moving lower in Tuesday trading, weighed down by pharmaceutical firms, as American depositary receipts of European stocks declined 0.5
Pharma Stocks Weigh Down European Equities in Thursday Trading
11:04 AM EST, 01/19/2023 (MT Newswires) -- Pharma stocks were weighing down European equities in Thursday trading as American depositary receipts of European stocks were moving 0.46% lower to 1,158.36
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today's session. Arrival (NASDAQ:ARVL) gained 36% to $0.7358.ione
Pharma Stocks Pull European Equities Lower in Wednesday Trading
11:04 AM EST, 01/11/2023 (MT Newswires) -- Pharma stocks were weighing down European equities in Wednesday trading as American depositary receipts of European stocks were off 0.11% at 1,143.08 on the
MorphoSys (OTCMKTS:MPSYF) Trading Up 15%
Shares of MorphoSys AG (OTCMKTS:MPSYF – Get Rating) traded up 15% during mid-day trading on Tuesday . The company traded as high as $16.30 and last traded at $16.30. 3,500 shares changed hands during
MorphoSys AG (NASDAQ:MOR) Receives $14.48 Consensus Price Target From Brokerages
Shares of MorphoSys AG (NASDAQ:MOR – Get Rating) have been assigned an average rating of "Hold" from the eight analysts that are covering the company, Marketbeat reports. Five investment analysts ha
MorphoSys (ETR:MOR) Given a €11.00 Price Target at JPMorgan Chase & Co.
MorphoSys (ETR:MOR – Get Rating) has been given a €11.00 ($11.70) price objective by JPMorgan Chase & Co. in a research report issued to clients and investors on Monday, Borsen Zeitung reports. JPMo
MorphoSys AG: MorphoSys Expects Topline Data From Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
MUNICH, GERMANY / ACCESSWIRE / January 9, 2023 / MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced today that topline data from the ongoing Phase 3 MANIFEST-2 study - a global, randomized, double-blind c
Company Overview
More
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
CEO： Mr. Jean-Paul Kress
Market： NASDAQ
Listing Date： 04/19/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet